Joe McDonough sat down for an interview with CURE to share his family’s story and the inspiration behind the B+ Foundation.

For nearly a decade, Mayra Andujar-Delgado has navigated the complexities of living with myelofibrosis, a journey she says was fundamentally shaped by the steady, compassionate guidance of her ...

Oya Gilbert, a 55-year-old who was diagnosed with multiple myeloma in 2017, encourages newly diagnosed patients, especially ...

For patients with blood cancer, it is crucial to own their own cancer journey, as a five-time cancer survivor and author ...

CURE spoke with Patricia I. Moreno, who holds a Ph.D. and is a licensed clinical psychologist and lead of evidence-based ...

Orserdu combined with Afinitor or Verzenio shows favorable tolerability and progression-free survival in ER-positive, ...

Tukysa, combined with Herceptin and Perjeta, extends progression-free survival in HER2+ metastatic breast cancer, showing ...

Trodelvy showed fewer severe side effects and required fewer dose reductions or discontinuations compared to chemotherapy in ...

Lynozyfic (linvoseltamab), a B-cell maturation antigen and CD3 bispecific antibody, showed a high overall response rate and a ...

Balanced nutrition, emphasizing complex carbohydrates, fiber, and reduced added sugars, plays a critical role in breast ...

AstraZeneca and Daiichi Sankyo’s Enhertu's breakthrough therapy designation as a post-neoadjuvant treatment option for ...

The HealthWell Foundation funded Brukinsa (zanubrutinib) for Mike, enabling him to afford the treatment and maintain his ...